InterCure Ltd. (INCR NASDAQ) stock market data APIs
$1.2079
-0.08(-6.6%)
as of May 29, 2026
Try our APIs with
free plan!
InterCure Ltd. Financial Data Overview
Price chart is built with
Anychart
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Prev. Close
1.2079
Open
1.1236
High
1.2256
Low
1.1143
52 wk Range
0.68-1.7698
Market Cap
65 618 K
Shares Outstanding
54 681 K
Revenue
243 M
EPS
0
Beta
0.354
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get InterCure Ltd. data using free add-ons & libraries
Get InterCure Ltd. Fundamental Data
InterCure Ltd. Fundamental data includes:
- Net Revenue: 243 M
- EBITDA: -55 343 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-18
- EPS/Forecast: 0.0477
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
InterCure Ltd. News
New
Ares Management bulks up on credit funds in first quarter of 2026
By Suzanne McGee and Isla Binnie PROVIDENCE, Rhode Island, May 15 (Reuters) - Private credit pioneer Ares Management disclosed a wide array of new or increased stakes in alternative asset vehic...
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
The Company reported over NIS 270 million in revenue, NIS 37 million in Net loss, NIS 47 million in Adjusted EBITDA and NIS 17 million in positive operating cash flow, reflecting strong resilience and...
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
NEW YORK and HERZLIYA, Israel, March 03, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“InterCure” or the “Company”) today announced that on February 25, 2026 the Comp...
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA, marking its twelfth consecutive half-year of positive Adjusted EBITDA. Revenue for 2025 repre...
Get InterCure Ltd. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
